WuXi AppTec Bolsters Supply Chain Resilience with PSCI Membership
Generado por agente de IAHarrison Brooks
domingo, 12 de enero de 2025, 7:11 pm ET1 min de lectura
MSCI--

WuXi AppTec, a global leader in pharmaceutical and life sciences R&D and manufacturing services, has announced its membership in the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner. This strategic move underscores WuXi AppTec's commitment to responsible business practices and supply chain resilience, further enhancing its position as a trusted partner in the global pharmaceutical and healthcare industry.
The Pharmaceutical Supply Chain Initiative (PSCI) is a leading global non-profit membership association dedicated to driving responsible value chains through its three modes of impact: Audit, Capability, and Projects. By joining PSCI as a Supplier Partner, WuXi AppTec aligns with PSCI's vision of achieving excellence in safety, environmental, and social outcomes across the global pharmaceutical and healthcare value chain.
Edward Hu, Vice Chairman of WuXi AppTec and Chairman of its ESG Committee, emphasized the company's dedication to fostering responsible business practices across the global supply chain. "We are pleased to join the PSCI as a Supplier Partner and reaffirm our commitment to fostering responsible business practices across the global supply chain," said Mr. Hu. "By adhering to PSCI standards and enhancing our value chain management, we remain dedicated to supporting our customers in delivering innovative new therapies to patients, working together towards a healthier and more sustainable future."
WuXi AppTec's membership in the PSCI is a testament to its unwavering commitment to sustainability and responsible business practices. The company has achieved several notable ESG recognitions in 2024, including ranking #1 in the Global Life Sciences Tools & Services Industry in S&P Global's Corporate Sustainability Assessment, receiving a gold medal in the EcoVadis business sustainability rating, and maintaining its AA MSCI ESG rating for the fourth consecutive year. In addition, WuXi AppTec was included in the 2024 Dow Jones Sustainability Indices (DJSI) and has been recognized as an Industry and Regional "Top-Rated" company by Sustainalytics.
WuXi AppTec's integration of ESG priorities in its global business operations has not only enhanced its supply chain resilience but also contributed to its outstanding ESG performance. By embedding sustainability at the core of its operations, WuXi AppTec is driving meaningful progress towards a healthier and more sustainable future for both its customers and the global pharmaceutical and healthcare industry.
In conclusion, WuXi AppTec's membership in the Pharmaceutical Supply Chain Initiative (PSCI) is a strategic move that bolsters its supply chain resilience and sustainability. By aligning with PSCI's vision and standards, WuXi AppTec reaffirms its commitment to responsible business practices and supports its customers in delivering innovative new therapies to patients worldwide.
PSCI--

WuXi AppTec, a global leader in pharmaceutical and life sciences R&D and manufacturing services, has announced its membership in the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner. This strategic move underscores WuXi AppTec's commitment to responsible business practices and supply chain resilience, further enhancing its position as a trusted partner in the global pharmaceutical and healthcare industry.
The Pharmaceutical Supply Chain Initiative (PSCI) is a leading global non-profit membership association dedicated to driving responsible value chains through its three modes of impact: Audit, Capability, and Projects. By joining PSCI as a Supplier Partner, WuXi AppTec aligns with PSCI's vision of achieving excellence in safety, environmental, and social outcomes across the global pharmaceutical and healthcare value chain.
Edward Hu, Vice Chairman of WuXi AppTec and Chairman of its ESG Committee, emphasized the company's dedication to fostering responsible business practices across the global supply chain. "We are pleased to join the PSCI as a Supplier Partner and reaffirm our commitment to fostering responsible business practices across the global supply chain," said Mr. Hu. "By adhering to PSCI standards and enhancing our value chain management, we remain dedicated to supporting our customers in delivering innovative new therapies to patients, working together towards a healthier and more sustainable future."
WuXi AppTec's membership in the PSCI is a testament to its unwavering commitment to sustainability and responsible business practices. The company has achieved several notable ESG recognitions in 2024, including ranking #1 in the Global Life Sciences Tools & Services Industry in S&P Global's Corporate Sustainability Assessment, receiving a gold medal in the EcoVadis business sustainability rating, and maintaining its AA MSCI ESG rating for the fourth consecutive year. In addition, WuXi AppTec was included in the 2024 Dow Jones Sustainability Indices (DJSI) and has been recognized as an Industry and Regional "Top-Rated" company by Sustainalytics.
WuXi AppTec's integration of ESG priorities in its global business operations has not only enhanced its supply chain resilience but also contributed to its outstanding ESG performance. By embedding sustainability at the core of its operations, WuXi AppTec is driving meaningful progress towards a healthier and more sustainable future for both its customers and the global pharmaceutical and healthcare industry.
In conclusion, WuXi AppTec's membership in the Pharmaceutical Supply Chain Initiative (PSCI) is a strategic move that bolsters its supply chain resilience and sustainability. By aligning with PSCI's vision and standards, WuXi AppTec reaffirms its commitment to responsible business practices and supports its customers in delivering innovative new therapies to patients worldwide.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios